Endometrial Cancer Treatment Market Trends and Segments Forecast To 2030
The report " Endometrial Cancer Treatment Market by Treatment (Chemotherapy, Radiation Therapy, Hormonal Therapy, Surgery), by Distribution Channel (Hospitals, Retail Pharmacies, Others), - Global Forecasts to 2030" The global Endometrial Cancer Treatment Market is projected to reach USD 27.8 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period 2024-2030. The growth of the market is majorly driven by the rising awareness about uterine diseases and available therapies. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22318 Competitive Dashboard: The prominent key players operating in the global Endometrial Cancer Treatment Market are Abbott Laboratories (U.S.) Becton, Dickinson and Company (U.S.) Ariad Pharmaceuticals, Inc. (U.S.) GlaxoSmithKline Plc (U.K.) Hoffmann-La Roche AG (Switzerland) Novartis AG (Switzerland) Merck & Co., Inc. (U.S.) Siemens Healthcare GmbH...